Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
LCTX
$1.07
+0.94%
LCTX · Lineage Cell Therapeutics, Inc.
$1.07
+0.01 (+0.94%)
At close · Aug 14
View the 10-K filed Mar 5, 2026
Customer concentration
— top 2 customers 92% of revenue
2 customers — 92% of revenue (the year ended December 31, 2025)
“For the year ended December 31, 2025, the Company’s top two customers collectively represented 92% of the Company’s total revenue.”
One customer — 92% of revenue (the year ended December 31, 2024)
“For the year ended December 31, 2024, the Company's top single customer represented 92% of the Company’s total revenue.”
Market Cap
$270.61M
Shares
252.91M
All earnings calls
Earnings call · FY2024 Q4
Lineage Cell Therapeutics, Inc. Q4 FY2024 Earnings Call
Lineage Cell Therapeutics, Inc. Q4 FY2024 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue · derived Q4
$2.87M
+37.4% YoY
Net income · derived Q4
-$3.27M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 10, 2025 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 10, 2025 · complete as-filed document